Research & Development

Canada’s PharmaDrug signs agreement to acquire Securedose Synthetics

Canadian company PharmaDrug has signed a definitive agreement to acquire Securedose Synthetics, a privately-held pharmaceutical research and development company.

ThermoGenesis opens cell and gene therapy facility in Sacramento, US

ThermoGenesis Holdings has opened a new 35,500ft² ReadyStart-IncuStart cGMP facility in Greater Sacramento in Northern California, US.

Caris, Moderna partner for mRNA-based oncology therapeutics advancement

Caris Life Sciences and Moderna have signed a new multi-year agreement for advancing mRNA-based oncology therapeutics.

Synaffix, ABL Bio partner to develop bispecific ADCs

Lonza company Synaffix has signed a licensing agreement with ABL Bio for the development of bispecific antibody drug conjugates (ADCs).

Innovac raises funding for lead programmes development

Innovac Therapeutics has raised $18m in Series Pre-A financing for funding the development of its lead programmes and manufacturing capabilities.

Allucent to expedite Covid-19 booster vaccines development

Allucent has received a contract from the Biomedical Advanced Research and Development Authority (BARDA) to expedite clinical research and development of next-generation booster vaccines for Covid-19.

Daiichi Sankyo to close Japanese research and development subsidiary

Daiichi Sankyo has announced its decision to shut down its Japanese research and development (R&D) subsidiary to further strengthen its capabilities.

Solu Therapeutics raises funds to develop CyTaC platform and drug candidates

Precision-medicine company Solu Therapeutics has raised $31m in seed financing to develop the Cytotoxicity Targeting Chimera (CyTaC) platform and drug candidates.

Viatris, Kindeva launch Breyna to treat asthma and COPD patients

Viatris and Kindeva Drug Delivery have launched Breyna (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol to treat certain asthma and chronic obstructive pulmonary disease (COPD) patients.